Beckman Coulter Diagnostics has launched an automated urinalysis system.
The fully automated DxU 1800 system solution combines a new chemistry analyser and consumables with microscopy technology.
“Despite urinalysis’s essential role and growing volume trends, many laboratories still rely on workflows requiring manual review, fragmented processes or separate chemistry and microscopy systems,” said Matthew Rhyner, VP and managing director, Hematology and Urinalysis Business for Beckman Coulter Diagnostics.
Urinalysis is one of the most widely used diagnostic tests across care settings. It plays a crucial role in detecting and monitoring disease progression and treatment response across infections, kidney disease and metabolic disorders such as chronic kidney disease, diabetes and urinary tract infections.
“As testing shifts to larger core and reference labs, these inefficiencies can create bottlenecks, variability and staffing strain. The DxU 1800 System helps standardise testing, increase throughput and reduce manual microscopy, empowering laboratories to deliver consistent results that enable confident clinical decisions at scale.”
The DxU 1800 system is designed to help laboratories achieve standardised results at scale. It combines the DxU 1800c Chemistry analyser with a DxU Iris Microscopy analyser. As a standalone, the DxU 1800c Chemistry analyser can process up to 300 samples per hour, supports expansive result storage of up to 2,000,000 samples and 100,000 strip images, and displays onscreen strip image results for easy review.
These combined technologies unify chemical analysis and particle imaging to help laboratories achieve more consistency and control. Overall, the integrated solution reduces manual handoffs and enables more standardised workflows across chemistry and microscopy.
According to Beckman Coulter, an expanded chemistry menu is expected to include creatinine and microalbumin assays. The addition could provide additional kidney function insight as part of routine screening testing without requiring changes to existing laboratory workflow.
The DxU 1800 system was unveiled at ADLM 2026 in Anaheim, California.
Earlier this year, Beckman Coulter expanded its Alzheimer’s portfolio.
